ES2129039T3 - Pirrolo(2,3-b)piridinas que tienen actividad terapeutica y un proceso para su fabricacion. - Google Patents

Pirrolo(2,3-b)piridinas que tienen actividad terapeutica y un proceso para su fabricacion.

Info

Publication number
ES2129039T3
ES2129039T3 ES92850067T ES92850067T ES2129039T3 ES 2129039 T3 ES2129039 T3 ES 2129039T3 ES 92850067 T ES92850067 T ES 92850067T ES 92850067 T ES92850067 T ES 92850067T ES 2129039 T3 ES2129039 T3 ES 2129039T3
Authority
ES
Spain
Prior art keywords
alkyl
halogen
piridinas
pirrolo
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92850067T
Other languages
English (en)
Inventor
Carin Briving
Marie Elebring
Stig Carlsson
Robert Carter
Thomas Kuhler
Peter Nordberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Application granted granted Critical
Publication of ES2129039T3 publication Critical patent/ES2129039T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Abstract

Un compuesto de la fórmula I I o una de sus sales farmacéuticamente aceptables, en la cual X representa O k -C, O-R 6 j -CH, N-O-R 6 k -C, o -CH2-; R 1 representa H, alquilo (1-6 C), CH2-O-R 7 , halógeno, fenilo o fenilo sustituido con alquilo (1-6 C), alcoxi (1-6 C), acilo (1-6 C), halógeno, o alcoxi (1-6 C)carbonilo; R 2 representa H, alquilo (1-6 C), CH2CN, O k CH2C-NH2 , halógeno, O-R 8 , N== / j CH2-N j n j === , S-CN, CH2OH, CH2CH, CF3, CH2NC o NH2; R 3 representa H, alquilo (1-6 C) , CF3, O-R 9 , NH2, halógeno, CN, O k S-R 10 , S-R 10 o NHCOR 10 ; R 4 y R 5 , que son iguales o diferentes, representan H, alquilo (1-6 C), CN, halógeno, O-R 11 , NO2, NH2, S-R 12 , NHCOR 13 , NHCOR 14 , k O CF3 o O k C-R 15 ; R 6 , R 7 , R 8 , R 9 , R 11 y R 13 , que son iguales o diferentes, representan H o alquilo (1-6 C); R 10 representa alquilo (1-6 C) o fenil-alquilo (1-6 C); R 12 y R 14 , que son iguales o diferentes, representan alquilo (1-6 C); R 15 representa H, alquilo (1-6 C), OH o alcoxi (1-6C); con la condición de que R 1 y R 2 no son simultáneamente H.
ES92850067T 1991-03-27 1992-03-25 Pirrolo(2,3-b)piridinas que tienen actividad terapeutica y un proceso para su fabricacion. Expired - Lifetime ES2129039T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9100920A SE9100920D0 (sv) 1991-03-27 1991-03-27 New active compounds

Publications (1)

Publication Number Publication Date
ES2129039T3 true ES2129039T3 (es) 1999-06-01

Family

ID=20382295

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92850067T Expired - Lifetime ES2129039T3 (es) 1991-03-27 1992-03-25 Pirrolo(2,3-b)piridinas que tienen actividad terapeutica y un proceso para su fabricacion.

Country Status (30)

Country Link
US (1) US5439917A (es)
EP (2) EP0509974B1 (es)
JP (1) JP3122792B2 (es)
CN (1) CN1067892A (es)
AP (1) AP309A (es)
AT (1) ATE175672T1 (es)
AU (1) AU655634B2 (es)
BG (1) BG98124A (es)
CA (1) CA2106880A1 (es)
DE (1) DE69228142T2 (es)
DK (1) DK0509974T3 (es)
ES (1) ES2129039T3 (es)
FI (1) FI934203A0 (es)
GR (1) GR3029834T3 (es)
HU (1) HUT65948A (es)
IE (1) IE920915A1 (es)
IL (1) IL101347A0 (es)
IS (1) IS3827A (es)
JO (1) JO1704B1 (es)
MA (1) MA22477A1 (es)
MX (1) MX9201324A (es)
NO (1) NO933425L (es)
NZ (1) NZ241943A (es)
SE (1) SE9100920D0 (es)
SK (1) SK103093A3 (es)
TN (1) TNSN92026A1 (es)
TW (1) TW198032B (es)
WO (1) WO1992017477A1 (es)
YU (1) YU30292A (es)
ZA (1) ZA921823B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100920D0 (sv) * 1991-03-27 1991-03-27 Astra Ab New active compounds
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
CN1615873A (zh) 1999-12-24 2005-05-18 阿文蒂斯药物有限公司 氮杂吲哚类化合物
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
GB0115109D0 (en) 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
WO2003082868A1 (en) 2002-03-28 2003-10-09 Eisai Co., Ltd. 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
CA2493618A1 (en) * 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
GB0305142D0 (en) 2003-03-06 2003-04-09 Eisai London Res Lab Ltd Synthesis
DE602004023921D1 (de) 2003-03-10 2009-12-17 Nycomed Gmbh Neues verfahren zur herstellung vonroflumilast
US6981980B2 (en) 2003-03-19 2006-01-03 Phagia Technology Self-inflating intragastric volume-occupying device
EP1628975A2 (en) 2003-05-16 2006-03-01 Eisai Co., Ltd. Jnk inhibitors
GB0405055D0 (en) * 2004-03-05 2004-04-07 Eisai London Res Lab Ltd JNK inhibitors
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
GB0516156D0 (en) 2005-08-05 2005-09-14 Eisai London Res Lab Ltd JNK inhibitors
CL2007002617A1 (es) 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
WO2008057802A2 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
CA2716367C (en) 2008-02-20 2015-05-26 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
KR102348222B1 (ko) * 2020-05-15 2022-01-10 대한민국 아동지킴이 과속방지시설

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100920D0 (sv) * 1991-03-27 1991-03-27 Astra Ab New active compounds

Also Published As

Publication number Publication date
GR3029834T3 (en) 1999-06-30
MA22477A1 (fr) 1992-10-01
NO933425D0 (no) 1993-09-24
AU1426092A (en) 1992-11-02
AP9200369A0 (en) 1992-04-30
CA2106880A1 (en) 1992-09-28
DE69228142D1 (de) 1999-02-25
JP3122792B2 (ja) 2001-01-09
DK0509974T3 (da) 1999-08-30
WO1992017477A1 (en) 1992-10-15
MX9201324A (es) 1992-10-01
AU655634B2 (en) 1995-01-05
IE920915A1 (en) 1992-10-07
ZA921823B (en) 1992-11-25
FI934203A (fi) 1993-09-24
AP309A (en) 1994-01-13
TNSN92026A1 (fr) 1993-06-08
ATE175672T1 (de) 1999-01-15
DE69228142T2 (de) 1999-07-22
EP0509974A1 (en) 1992-10-21
EP0580616A1 (en) 1994-02-02
CN1067892A (zh) 1993-01-13
SK103093A3 (en) 1994-08-10
FI934203A0 (fi) 1993-09-24
EP0509974B1 (en) 1999-01-13
NO933425L (no) 1993-10-25
JPH06506448A (ja) 1994-07-21
JO1704B1 (en) 1992-12-15
TW198032B (es) 1993-01-11
HUT65948A (en) 1994-08-29
HU9302741D0 (en) 1993-12-28
IL101347A0 (en) 1992-11-15
US5439917A (en) 1995-08-08
SE9100920D0 (sv) 1991-03-27
YU30292A (sh) 1995-01-31
IS3827A (is) 1992-09-28
BG98124A (en) 1994-11-15
NZ241943A (en) 1993-12-23

Similar Documents

Publication Publication Date Title
ES2129039T3 (es) Pirrolo(2,3-b)piridinas que tienen actividad terapeutica y un proceso para su fabricacion.
HUP0401783A2 (hu) 3,4-Diszubsztituált ciklobutén-1,2-dionok mint CXC-kemokin receptor ligandumok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
ES2192588T3 (es) 4-(arilaminometilen)-2,4-dihidro-pirazol-3-onas.
AR009783A1 (es) Compuesto, composiciones farmaceuticas y metodos para efectuar una actividad neuronal en un animal
AR022636A1 (es) Derivados de la 16-halo-epotilona, los procedimientos para prepararlos y el empleo farmaceutico de los mismos
NO923744L (no) Nye 2-substituerte indan-2-mercaptoacetylamidderivater anvendbare som inhibitorer av enkefalinase og ace
PL338129A1 (en) Crystalline form of a derivative of n-phenyl-2-dipyrimidin amine, methods of obtaining same and apllication thereof
UY26512A1 (es) Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
PL290758A1 (en) Method of obtaining novel heterocyclene compounds
UY27338A1 (es) Nuevos derivados de ácido sulfónico
CO5040027A1 (es) Mezclas fungicidas de eteres fenilbencilicos y/o cabamatos con dinitrofenoles, procedimieto para combatir hongos dani- nos con dichas mezclas; utiliacion de dichos compuestos en la preparacion de dichas mezclas y agentes fungicidas for- mulados con d
CY1108793T1 (el) Καμπτοθεκινες με τροποποιημενο λακτονικο δακτυλιο
JPS5344544A (en) Substituted phenylurea derivatives, their preparation, and selective herbicide comprising the corresponding compounds
EA200300392A1 (ru) Производные пиперазина с мостиковой связью
DK1274685T3 (da) Et pyridin-N-oxid-derivat og fremgangsmåde til omdannelse deraf til farmaceutisk effektive forbindelser
AR053989A1 (es) Compuestos espiro-hidantoina sustituidos con piridilo. composiciones farmaceuticas y procesos de obtencion.
HRP20080521T3 (en) Orodispersible pharmaceutical composition of an antithrombotic compound
ES2096099T3 (es) Perhidro-1h-pirido(1,2,a)pirazinas 2-sustituidas neurolepticas.
PT1000067E (pt) Tiazolobenzo-heterociclos sua preparacao e medicamentos que os contem
DK0539326T3 (da) Bis(phenyl)ethanderivater
GT197955866A (es) 3-cloro-2,6-dinitro-n-(fenil substituido)-4-(trifluorometil)bencenaminas.
DK308980A (da) Azolylalkenoler samt fysiologisk acceptable syreadditionssalte og metalsaltkomplekser deraf deres fremstilling og anvendelse som fungicider
CO5021190A1 (es) Agentes terapeuticos
ES2051891T3 (es) Procedimiento para preparar derivados de cisteina.
HUP0003555A2 (hu) Gombaellenes hatású triazolszármazékok, ezeket tartalmazó gyógyszerkészítmények és intermedierjük

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 509974

Country of ref document: ES